Digestive & Intestinal Remedies (Pharmacies) - Italy

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$410.80m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.67%, resulting in a market volume of US$424.80m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$7.00 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Italy is experiencing steady growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Italian consumers are increasingly seeking natural and herbal remedies for digestive and intestinal issues. This shift in preference is driven by a growing awareness of the potential side effects of conventional medication and a desire for more holistic approaches to healthcare. As a result, there has been an increased demand for herbal supplements, probiotics, and other natural remedies in the Digestive & Intestinal Remedies market.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Italy is the rising popularity of probiotics. Probiotic supplements, which contain beneficial bacteria that support gut health, are gaining traction among consumers looking for natural solutions to digestive problems. The market is also witnessing a rise in the demand for digestive enzymes, which help break down food and improve digestion. Another trend in the market is the increasing availability of over-the-counter (OTC) digestive remedies in pharmacies. This has made it easier for consumers to access these products without the need for a prescription. The convenience and accessibility of OTC remedies have contributed to the growth of the market.

Local special circumstances: Italy has a strong tradition of herbal medicine and natural remedies. This cultural preference for natural treatments has influenced the Digestive & Intestinal Remedies market in the country. Italian consumers are more inclined to opt for herbal and natural remedies, which has created opportunities for both local and international companies to introduce and promote their products in the market.

Underlying macroeconomic factors: The growth of the Digestive & Intestinal Remedies market in Italy is also influenced by underlying macroeconomic factors. The country's aging population and increasing prevalence of lifestyle diseases such as obesity and gastrointestinal disorders have contributed to the demand for digestive and intestinal remedies. Additionally, the rising healthcare costs and the burden on the public healthcare system have led individuals to seek self-care solutions, including over-the-counter remedies. In conclusion, the Digestive & Intestinal Remedies market in Italy is witnessing growth due to changing customer preferences towards natural and herbal remedies, emerging trends such as the popularity of probiotics and OTC remedies, local special circumstances favoring natural treatments, and underlying macroeconomic factors such as an aging population and rising healthcare costs.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.